Sauer Paul 4
4 · Vaxcyte, Inc. · Filed Sep 24, 2021
Insider Transaction Report
Form 4
Vaxcyte, Inc.PCVX
Sauer Paul
SVP Process Dev, Manufacturing
Transactions
- Sale
Common Stock
2021-09-22$25.20/sh−5,307$133,724→ 36,125 total
Footnotes (3)
- [F1]The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.
- [F2]The price reported is a weighted-average price. The shares were sold at prices ranging from $25.00 to $25.45. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
- [F3]Includes 1,841 shares acquired under the Employee Stock Purchase Plan on May 17, 2021.